Droperidol and ondansetron in vitro electrophysiological drug interaction study

Fundamental and Clinical Pharmacology

Volumn 23, Issue 6, 2009, Pages 719-726

  Weissenburger, Jacques ^a,b   Funck Brentano, Christian ^b   Jaillon, Patrice ^a,b   Charbit, Beny ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Action potential duration; Anti emetic; Droperidol; Ondansetron; Purkinje fibres

Indexed keywords

DROPERIDOL; ONDANSETRON;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENCY; FEMALE; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; IC 50; IN VITRO STUDY; MALE; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; PURKINJE FIBER; QT PROLONGATION; RABBIT;

ACTION POTENTIALS; ANIMALS; ANTIEMETICS; DROPERIDOL; DRUG COMBINATIONS; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; MALE; ONDANSETRON; PURKINJE FIBERS; RABBITS;

EID: 70449499228     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00735.x     Document Type: Article

References (24)

1. Charbit B., Albaladejo P., Funck-Brentano C., Legrand M., Samain E., Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology (2005) 102 1094 1100.
2. Charbit B., Alvarez J.C., Dasque E., Abe E., Demolis J.L., Funck-Brentano C. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology (2008) 109 206 212.
3. Schwoerer A.P., Blutner C., Brandt S. et al. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization. Anesthesiology (2007) 106 967 976.
4. Drolet B., Zhang S., Deschenes D. et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J. Cardiovasc. Electrophysiol. (1999) 10 1597 1604. (Pubitemid 30020497)
5. Kuryshev Y.A., Brown A.M., Wang L., Benedict C.R., Rampe D. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J. Pharmacol. Exp. Ther. (2000) 295 614 620.
6. de Lorenzi F.G., Bridal T.R., Spinelli W. Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes. Br. J. Pharmacol. (1994) 113 527 535.
7. Cavero I., Mestre M., Guillon J.M., Crumb W. Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias. Expert Opin. Pharmacother. (2000) 1 947 973.
8. Roden D.M. Drug-induced prolongation of the QT interval. N. Engl. J. Med. (2004) 350 1013 1022.
9. Vormberge T., Hoffmann M., Himmel H. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve. J. Pharmacol. Toxicol. Methods (2006) 54 130 140.
10. Milberg P., Ramtin S., Monnig G. et al. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block. J. Cardiovasc. Pharmacol. (2004) 44 278 286.
11. Redfern W.S., Carlsson L., Davis A.S. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. (2003) 58 32 45.
12. Olschewski A., Hempelmann G., Vogel W., Safronov B.V. Suppression of potassium conductance by droperidol has influence on excitability of spinal sensory neurons. Anesthesiology (2001) 94 280 289.
13. Olschewski A., Brau M.E., Hempelmann G., Vogel W., Safronov B.V. Differential block of fast and slow inactivating tetrodotoxin-sensitive sodium channels by droperidol in spinal dorsal horn neurons. Anesthesiology (2000) 92 1667 1676.
14. 2+ sensitivity, and contraction in rat ventricular myocytes. Anesthesiology (2005) 102 1165 1173.
15. Chezalviel-Guilbert F., Davy J.M., Poirier J.M., Weissenburger J. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes. J. Am. Coll. Cardiol. (1995) 26 787 792.
16. Fan J.S., Liu T.F. Role of inward and delayed rectifier currents in generation of early afterdepolarization in guinea pig ventricular myocytes under K(+)-free or low K+ superfusion. Methods Find. Exp. Clin. Pharmacol. (1996) 18 25 32.
17. Merot J., Charpentier F., Poirier J.M., Coutris G., Weissenburger J. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol. Cardiovasc. Res. (1999) 44 303 314.
18. Hondeghem L.M., Carlsson L., Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation (2001) 103 2004 2013.
19. Aubert M., Osterwalder R., Wagner B. et al. Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans. Drug Saf. (2006) 29 237 254.
20. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E. et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N. Engl. J. Med. (1999) 341 857 865.
21. Adamantidis M.M., Kerram P., Caron J.F., Dupuis B.A. Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibers. J. Pharmacol. Exp. Ther. (1993) 266 884 893.
22. Monassier L., Manoury B., Bellocq C. et al. Sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart. J. Pharmacol. Exp. Ther. (2007) 322 341 350.
23. Thomsen M.B., Matz J., Volders P.G., Vos M.A. Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias. Pharmacol. Ther. (2006) 112 150 170.
24. Charbit B., Funck-Brentano C. Droperidol-induced proarrhythmia. The beginning of an answer? Anesthesiology (2007) 107 524 526.